Results 291 to 300 of about 359,662 (357)

Increased levels of syndecan-3 are associated with childhood obesity. [PDF]

open access: yesiScience
Muñoz-Moreno D   +14 more
europepmc   +1 more source

Preliminary evidence of improved liver biomarkers in adolescents with obesity and suspected metabolic dysfunction‐associated steatotic liver disease treated with semaglutide: A case series

open access: yesJPGN Reports, EarlyView.
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) affects 30%–40% of youth with obesity and lacks approved pharmacologic therapies. In this single‐center retrospective case series at a tertiary care safety‐net children's hospital, we evaluated five adolescents (mean age: 17.0 years; 100% Hispanic; 60% male; mean body mass index:
Rachel Schenker   +3 more
wiley   +1 more source

Childhood obesity and DNA methylation in an epigenome-wide association study: findings from the Hokkaido Birth Cohort. [PDF]

open access: yesClin Epigenetics
Iwata H   +15 more
europepmc   +1 more source

First 1000 Days Strategies to Prevent Childhood Obesity: A Narrative Review and Recommendations From the EndObesity Consortium. [PDF]

open access: yesPediatr Obes
Schipper MC   +20 more
europepmc   +1 more source

The Weight of Emotions: Childhood Obesity and Psychosocial Well-Being in Saudi Arabia. [PDF]

open access: yesHealthcare (Basel)
Majzoub R   +11 more
europepmc   +1 more source

ABC of obesity. Childhood obesity.

open access: yesBMJ (Clinical research ed.), 2006
Reilly, J. J, Wilson, D.
openaire   +2 more sources

Home - About - Disclaimer - Privacy